EDAP TMS SA (FOCL) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$4.24

From 52W high−32.65%

Volume7854.00

Market cap$201.62M

P/E (TTM)—

P/S (TTM)2.9x

Div yield—

Key dataNov 4, 2026

Open

$4.24

From 52W high

−32.65%

Volume

7854.00

Market cap

$201.62M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−8.3x

P/E (TTM)

—

RSI (14)

53.6

MomentumView details →

1D Return

+3.89%

YTD Return

+32.52%

SummaryUpdated Jun 1, 2026

EDAP TMS S.A. (NASDAQ:EDAP) is a French medical device company founded in 1979 and headquartered in Lyon, France. The company went public in 1997 and specializes in developing, manufacturing, and marketing minimally invasive medical devices for treating urological diseases. EDAP has evolved from a diversified medical device company into one increasingly focused on its High Intensity Focused Ultrasound (HIFU) technology platform, particularly for prostate cancer treatment. The company operates globally with direct sales operations in the United States, Europe, and Asia, serving hospitals, urology clinics, and research institutions worldwide.

Ask drillr about EDAP TMS SA →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−8.3x

EV/Sales

3.2x

P/S (TTM)

2.9x

P/B (TTM)

−62.5x

ProfitabilityView details →

Gross Margin

45.98%

Net Margin

−56.25%

EBITDA Margin

−38.23%

ROE (TTM)

1205.94%

ROA (TTM)

−52.17%

Asset Turnover

0.94x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+6.90%

EPS CAGR 3Y

−41.82%

EBITDA YoY

—

MomentumView details →

1D Return

+3.89%

YTD Return

+32.52%

1Y Return

+109.62%

RSI (14)

53.6

vs 50D SMA

+2.54%

vs 200D SMA

−1.21%

Capital & dividendView details →

Debt/Equity

−12.37x

Current Ratio

1.60x

Quick Ratio

1.38x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.39

EPS Surprise

−95.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.24

Avg Surprise (4Q)

−95.00%

Rev Surprise

−12.49%

Financials snapshotView financials →

Revenue (TTM)

69.14M

Net Income (TTM)

−38.89M

Op. CF (TTM)

−12.90M

Next earningsNov 5, 2026 →

Latest newsMore news →

EDAP TMS SA announced a public offering expected to raise gross proceeds of $40 million.84d ago

EDAP TMS SA reported Q2 2026 revenue of $13.2 million, up 39% year-over-year, with a net loss of $14.5 million and diluted EPS of -$0.39.84d ago

Similar companies

SHOULDER INNOVATIONS, INC.SI Inspira Technologies Oxy B.H.N. Ltd.QTEX Cofoe Medical Technology Co.,Ltd.01187.HK Ekso Bionics Holdings, Inc. Common StockCHRN 科美诊断688468.SH Jenscare Scientific Co., Ltd.09877.HK Find similar companies →

Latest newsMore news →

EDAP TMS SA announced a public offering expected to raise gross proceeds of $40 million.84d ago EDAP TMS SA reported Q2 2026 revenue of $13.2 million, up 39% year-over-year, with a net loss of $14.5 million and diluted EPS of -$0.39.84d ago